Double-network skin repair hydrogel and preparation method thereof

Through the combination of dual network structure and functionalized MOFs, the shortcomings of hydrogels in drug release control, versatility and structural stability are solved, and the continuous release of drugs and high mechanical properties are achieved, which meets the repair of complex skin lesions. Demand, detailed preparation methods are provided to ensure the consistency and stability of product performance.

CN118976142AActive Publication Date: 2024-11-19XIAMEN CHUNSHANG HEALTH TECHNOLOGY CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411067347.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-19
Estimated Expiration
2044-08-06

AI Technical Summary

Technical Problem

Existing hydrogels have shortcomings in drug release control, versatile integration, structural stability and flexibility, and the repeatability and controllability of the preparation process, which is difficult to meet the needs of complex skin lesions repair.

Method used

By designing a dual network structure, precisely adjusting crosslink density and crosslinking conditions, combining functionalized metal organic framework materials (MOFs) and polymer networks, the initial rapid and late-stage slow release of drugs can be achieved, and the antibacterial and drug sustained release functions are integrated. , optimize material selection and crosslinking strategies to ensure functional synergy, while providing detailed preparation steps and parameter controls to ensure consistency and stability of product performance.

Benefits of technology

It significantly improves the drug release control effect, achieves a balance of high mechanical strength and flexibility, ensures the continuous release and therapeutic effect of the drug, improves the comprehensive performance and application reliability of the hydrogel, and meets the many aspects of the skin repair process. type of demand.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118976142A_ABST
    Figure CN118976142A_ABST
Patent Text Reader

Abstract

The invention discloses double-network skin repair hydrogel and a preparation method thereof, and relates to the technical field of skin hydrogel, and the technical scheme is as follows: dissolving 2-aminoterephthalic acid and copper nitrate in N, N-dimethylformamide, heating, centrifugally separating, washing and drying to obtain MOFs powder; and dispersing the MOFs powder in deionized water, and adding silver nanoparticles to obtain the functionalized MOFs. Dissolving azathiopurine in water, and performing ultrasonic treatment on the dissolved azathiopurine and the functionalized MOFs to form the drug carrier. The polymer and the cross-linking agent are heated in the water to form a first network. Mixing a drug carrier with the first network, and heating to form the completely cross-linked dual-network gel. According to the double-network hydrogel disclosed by the invention, by accurately controlling the crosslinking density and conditions, rapid initial release and later slow release of the medicine are realized, and the treatment effect is remarkably improved. The structure integrates antibacterial and slow-release functions, the medicine is loaded through the functionalized MOFs, meanwhile, high mechanical strength and flexibility are ensured, and the hydrogel is suitable for the dynamic environment of the skin.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of skin hydrogels, and in particular to a double-network skin repairing hydrogel and a preparation method thereof. Background Art

[0002] In recent years, with the development of biomedical materials and regenerative medicine, hydrogels, as a material with excellent biocompatibility, adjustable mechanical properties and high water absorption, have been widely used in skin repair, drug delivery and tissue engineering. The application of hydrogels in skin repair is particularly important, as they can provide a protective barrier for damaged skin, maintain a moist environment and promote tissue regeneration. However, traditional single-network hydrogels have certain limitations in drug release control, multifunctionality and mechanical properties, and are difficult to meet the needs of complex skin damage repair.

[0003] In order to improve the comprehensive performance of hydrogels, researchers have made many attempts in structural design and material modification. For example, by adjusting the cross-linking density and type of cross-linking agent of hydrogels, their mechanical properties and drug release characteristics can be improved to a certain extent. In addition, adding nanoparticles or other functional materials to hydrogels can also give them multiple functions such as antibacterial and self-healing. However, these methods can often only partially solve the problem, and there is still a lot of room for improvement in comprehensive performance.

[0004] Despite the existence of a variety of modification technologies and material design strategies, existing hydrogels still face many challenges in practical applications. First, precise control of drug release is a difficult point. Traditional hydrogels lack precise control methods for regulating drug release rates, resulting in too fast initial drug release or insufficient later release, and unable to achieve the desired therapeutic effect. Most hydrogels are unable to provide sustained drug release in the later stages while quickly relieving symptoms in the early stages, thereby meeting long-term treatment needs.

[0005] In terms of mechanical properties, existing hydrogels also have shortcomings. Usually, in order to achieve a higher drug release rate, the structural design of hydrogels is often loose, resulting in insufficient mechanical strength and elasticity. In this case, the hydrogel is easily damaged or deformed during the application process, and it is difficult to provide long-term and stable physical protection. In addition, although some modification strategies can improve the mechanical strength of hydrogels, they will reduce their flexibility and elasticity, affecting the comfort and adaptability of use.

[0006] The realization of multifunctionality is also a major problem of existing technologies. Although the addition of nanoparticles or functional materials can give hydrogels certain antibacterial, self-repair and other functions, how to effectively integrate multiple functions without affecting their basic performance and ensure the synergistic effect of these functions during the application process is still a technical difficulty. In practical applications, existing multifunctional hydrogels are often difficult to achieve the expected comprehensive effects due to functional conflicts or incompatibility.

[0007] In addition, the existing technology also has obvious deficiencies in the repeatability and controllability of the preparation process. Since the hydrogel preparation process involves multiple complex steps, the parameter settings of each step have a significant impact on the performance of the final product. The existing technology lacks a detailed and operational preparation method, resulting in inconsistent performance of different batches of products, making it difficult to ensure reliability and stability in practical applications.

[0008] In order to solve the above-mentioned technical problems, the present invention proposes a double-network skin repair hydrogel and a preparation method thereof, aiming to solve the problems of drug release control, multifunctional integration, structural stability and flexibility, and repeatability and controllability of the preparation process. Specifically, the present invention achieves the initial rapid release and the later slow release of the drug by precisely regulating the cross-linking density and cross-linking conditions of the double-network structure, thereby ensuring the effective utilization and sustained effect of the drug in the process of skin damage repair. At the same time, the antibacterial, self-repair and drug sustained-release capabilities of the hydrogel are improved, and the synergistic effect of each function is ensured by optimizing material selection and cross-linking strategies. In addition, the present invention provides detailed preparation steps and parameter control to ensure the operability and repeatability of each step, thereby ensuring the consistency and stability of product performance. These technical improvements not only improve the comprehensive performance of the double-network skin repair hydrogel, but also provide technical guarantees for its wide promotion in practical applications. Summary of the invention

[0009] In order to achieve the above-mentioned purpose of the invention and to solve the above-mentioned technical problems, the present invention provides a method for preparing a double-network skin repair hydrogel, comprising the following steps:

[0010] S1: dissolving 2-aminoterephthalic acid and copper nitrate in N,N-dimethylformamide and stirring until completely dissolved; then heating for reaction, cooling to room temperature, centrifuging to obtain MOFs solid, and then washing and drying to constant weight to obtain MOFs powder;

[0011] S2: Re-dispersing the MOFs powder in deionized water to form a MOFs suspension, adding silver nanoparticles to the MOFs solution, stirring evenly, and obtaining a functionalized MOFs solution;

[0012] S3 drug loading: dissolve azathioprine in deionized water, add it to the functionalized antibacterial MOFs solution, and treat it with ultrasound to obtain functionalized drug carrier MOFs;

[0013] S4 first network: dissolving poly(N-isopropylacrylamide) and polyethylene glycol in deionized water, adding N,N'-methylenebisacrylamide, heating and stirring to form a preliminary cross-linked gel network;

[0014] S5 Second Network: Disperse 50% of the functionalized drug carrier MOFs evenly in the first network gel, stir evenly, add N,N'-methylenebisacrylamide as a secondary crosslinking agent again, and then add the remaining functionalized drug carrier MOFs, heat and stir to form a completely crosslinked double network hydrogel, cool to room temperature, and stand at low temperature to form a gel;

[0015] S6 Finally, pour the gel into the mold and leave it to solidify.

[0016] Preferably, in step S1, 2-aminoterephthalic acid is 2-4 parts, copper nitrate is 1.5-2.5 parts, and N,N-dimethylformamide is 90-110 parts.

[0017] Preferably, in step S1, the heating temperature is 150° C. and the reaction time is 10-14 hours.

[0018] Preferably, in step S2, the MOFs powder is 2-4 parts, the deionized water is 90-110 parts, and the silver nanoparticles are 0.5-1.5 parts.

[0019] Preferably, in step S3, the amount of azathioprine is 0.4-0.6 parts, and the amount of deionized water is 10-20 parts.

[0020] Preferably, in step S4, poly(N-isopropylacrylamide) is 8-12 parts, polyethylene glycol is 4-6 parts, deionized water is 90-110 parts, N,N'-methylenebisacrylamide is 0.2-0.4 parts, the heating temperature is 60-70 degrees Celsius, and the time is 20-30 minutes.

[0021] Preferably, in step S5, the amount of N,N'-methylenebisacrylamide is 0.4-0.6 parts.

[0022] Preferably, in step S5, the heating temperature is 70-80 degrees Celsius and the stirring time is 30-40 minutes.

[0023] Preferably, in step S6, the standing temperature is 4° C. and the standing time is 1-2 hours.

[0024] The present invention also provides a double-network skin repair hydrogel, which is prepared by the above method.

[0025] The technical solution provided by the present invention brings beneficial effects:

[0026] The present invention achieves the initial rapid release and later slow release of the drug by accurately regulating the cross-linking density and cross-linking conditions of the dual network structure, and significantly improves the effect of drug release control. Specifically, the first network is composed of poly (N-isopropylacrylamide) (PNIPAM) and polyethylene glycol (PEG), and a loose structure is formed by a lower concentration of cross-linking agent and a shorter cross-linking time. This design allows the drug to be released rapidly in the early stage, quickly relieves the pain and inflammation caused by skin damage, and provides an efficient initial therapeutic effect. The second network forms a dense cross-linked structure by adding a higher concentration of cross-linking agent and a longer cross-linking time to control the slow release of the drug. This design ensures that the drug can be continuously released in the later stage, providing a long-lasting therapeutic effect, and avoiding the problem of poor therapeutic effect caused by traditional hydrogels due to excessively fast initial release or insufficient later release.

[0027] The present invention successfully integrates antibacterial and drug sustained-release functions by introducing functionalized metal organic framework materials (MOFs) into double network hydrogels, significantly improving the overall therapeutic effect. Specifically, MOFs are functionalized during the preparation process and loaded with antibacterial agents and drugs (such as azathioprine). This multifunctional integration enables the hydrogel to effectively inhibit bacterial infection during application, and through the structural characteristics of MOFs, the precise release and sustained-release effect of drugs are achieved. Compared with traditional single-functional hydrogels, the multifunctional design of the present invention enables it to provide a more comprehensive and lasting therapeutic effect in practical applications.

[0028] The present invention successfully achieves a balance between high mechanical strength and flexibility through the design of a dual network structure, so that the hydrogel can adapt to the dynamic environment of the skin during application. The first network provides basic mechanical strength and flexibility, and forms a structure with certain elasticity and flexibility by reasonably selecting the ratio of PNIPAM and PEG, and controlling the amount of cross-linking agent and the cross-linking time. The second network further enhances the structural stability of the hydrogel through secondary cross-linking, ensuring that it will not be easily damaged or deformed during application. Compared with the hydrogel with a single structure in the prior art, the dual network structure of the present invention significantly improves the mechanical properties, so that it has higher strength and stability while maintaining flexibility, meeting the various needs in the skin repair process.

[0029] The present invention not only improves the comprehensive performance of the double-network skin repair hydrogel through these technical improvements, but also provides technical guarantees for its wide promotion in practical applications. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1This is a photo of skin healing according to an embodiment of the present invention. DETAILED DESCRIPTION

[0031] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. Of course, the specific embodiments described here are only used to explain the present invention and are not used to limit the present invention.

[0032] Example 1

[0033] Preparation method of double network skin repair hydrogel:

[0034] S1. Preparation of MOFs Precursors

[0035] Dissolve 3.0 parts of 2-aminoterephthalic acid and 2.0 parts of copper nitrate in 100 parts of N,N-dimethylformamide and stir until completely dissolved;

[0036] The solution was placed in a sealed reactor, heated to 150°C, and reacted for 12 hours;

[0037] After the reaction is completed, the mixture is cooled to room temperature and centrifuged to obtain MOFs solid;

[0038] The mixture was washed with DMF and deionized water three times respectively and then dried in a vacuum oven to constant weight to obtain MOFs powder.

[0039] S2.MOFs functionalization

[0040] 3.0 parts of MOFs powder were redispersed in 100 parts of deionized water to form a MOFs suspension.

[0041] 1.0 part of silver nanoparticles was added to the MOFs suspension and stirred evenly to obtain a functionalized MOFs solution.

[0042] S3. Drug loading

[0043] 0.5 parts of azathioprine were dissolved in 15 parts of deionized water.

[0044] The drug solution was added into the functionalized antibacterial MOFs solution and ultrasonicated for 30 min to obtain the functionalized drug carrier MOFs.

[0045] S4. Preparation of the First Network

[0046] Dissolve 10 parts of poly(N-isopropylacrylamide) PNIPAM and 5 parts of polyethylene glycol PEG in 100 parts of deionized water, and add 0.3 parts of N,N'-methylenebisacrylamide MBA;

[0047] The mixture was heated to 66°C and maintained under stirring for 25 minutes to form a preliminary cross-linked gel network.

[0048] S5. Preparation of the Second Network

[0049] Disperse 50% of the functionalized drug carrier MOFs uniformly in the first network gel and stir evenly;

[0050] 0.5 parts of MBA was added again as a secondary cross-linking agent, and then the remaining functionalized drug carrier MOFs were added;

[0051] Heating to 78°C and maintaining for 35 min formed a fully cross-linked double network hydrogel;

[0052] Cool to room temperature and let stand to gel.

[0053] S6. Molding and curing

[0054] The prepared double network hydrogel was poured into the mold and placed in a 4°C environment for 1.5 hours to ensure that the gel was fully formed and solidified.

[0055] Example 2

[0056] Prepared according to the same preparation method as in Example 1, except that 2-aminoterephthalic acid (2 parts by mass), copper nitrate (2.5 parts by mass), and DMF (90 parts by mass) were used in step S1;

[0057] Example 3

[0058] The preparation was carried out according to the same preparation method as in Example 1, except that 2-aminoterephthalic acid (4 parts by mass), copper nitrate (1.5 parts by mass) and DMF (110 parts by mass) were used in step S1.

[0059] Example 4

[0060] The preparation was carried out according to the same preparation method as in Example 1, except that silver nanoparticles (0.5 parts by mass), azathioprine (0.6 parts by mass), and deionized water (20 parts by mass) were used in steps S2 and S3.

[0061] Example 5

[0062] The preparation was carried out according to the same preparation method as in Example 1, except that silver nanoparticles (1.5 parts by mass), azathioprine (0.4 parts by mass), and deionized water (20 parts by mass) were used in steps S2 and S3.

[0063] Example 6

[0064] The preparation was carried out in the same manner as in Example 1, except that 0.2 parts by mass of MBA was used in step S4 and 0.6 parts by mass of MBA was used in step S5.

[0065] Example 7

[0066] The preparation was carried out in the same manner as in Example 1, except that 0.4 mass parts of MBA were used in step S4 and 0.4 mass parts of MBA were used in step S5.

[0067] Example 8

[0068] The preparation method is the same as that in Example 1, except that in step S4, PNIPAM (12 parts by mass) and PEG (4 parts by mass) are used.

[0069] Example 9

[0070] The preparation was carried out in the same manner as in Example 1, except that

[0071] The first network heating temperature is 60℃, the time is 20 minutes

[0072] The second network heating temperature is 80°C and the stirring time is 40 minutes

[0073] Example 10

[0074] The preparation was carried out in the same manner as in Example 1, except that

[0075] The first network heating temperature is 70℃, the time is 20 minutes

[0076] The second network heating temperature is 80°C and the stirring time is 30 minutes

[0077] Comparative Example 1

[0078] Preparation method of double network skin repair hydrogel:

[0079] (1) 10 parts of poly (N-isopropylacrylamide) PNIPAM and 5 parts of polyethylene glycol PEG were dissolved in 100 parts of deionized water, and 0.5 parts of silver nanoparticles, 0.25 parts of azathioprine, and 0.3 parts of N,N'-methylenebisacrylamide MBA were added;

[0080] The mixture was heated to 66°C and maintained under stirring for 25 minutes to form a preliminary cross-linked gel network.

[0081] (2) adding 0.5 parts of MBA as a secondary crosslinking agent again, and then adding 0.5 parts of silver nanoparticles and 0.25 parts of azathioprine;

[0082] Heating to 78°C and maintaining for 35 min formed a fully cross-linked double network hydrogel;

[0083] Cool to room temperature and let stand to gel.

[0084] (3) Pour the prepared double network hydrogel into a mold and place it in a 4°C environment for 1.5 hours to ensure that the gel is fully formed and solidified.

[0085] Comparative Example 2

[0086] Preparation method of double network skin repair hydrogel:

[0087] S1. Preparation of MOFs Precursors

[0088] Dissolve 3.0 parts of 2-aminoterephthalic acid and 2.0 parts of copper nitrate in 100 parts of N,N-dimethylformamide and stir until completely dissolved;

[0089] The solution was placed in a sealed reactor, heated to 150°C, and reacted for 12 hours;

[0090] After the reaction is completed, the mixture is cooled to room temperature and centrifuged to obtain MOFs solid;

[0091] The mixture was washed with DMF and deionized water three times respectively and then dried in a vacuum oven to constant weight to obtain MOFs powder.

[0092] S2.MOFs functionalization

[0093] 3.0 parts of MOFs powder were redispersed in 100 parts of deionized water to form a MOFs suspension.

[0094] 1.0 part of silver nanoparticles was added to the MOFs suspension and stirred evenly to obtain a functionalized MOFs solution.

[0095] S3. Drug loading

[0096] 0.5 parts of azathioprine were dissolved in 15 parts of deionized water.

[0097] The drug solution was added into the functionalized antibacterial MOFs solution and ultrasonicated for 30 min to obtain the functionalized drug carrier MOFs.

[0098] S4. Preparation of gel

[0099] 10 parts of poly(N-isopropylacrylamide) PNIPAM and 5 parts of polyethylene glycol PEG were dissolved in 100 parts of deionized water, the functionalized drug carrier MOFs were uniformly dispersed in the gel, and 0.3 parts of N,N'-methylenebisacrylamide MBA were added;

[0100] Heating to 66°C and maintaining under stirring for 25 minutes to form a preliminary cross-linked gel network;

[0101] Cool to room temperature and let stand to gel.

[0102] S5. Molding and curing

[0103] The prepared double network hydrogel was poured into the mold and placed in a 4°C environment for 1.5 hours to ensure that the gel was fully formed and solidified.

[0104] Experimental test:

[0105] 1. Drug release control test

[0106] Samples: The hydrogel samples of the present invention and comparative examples were prepared.

[0107] Procedure: Prepare hydrogel discs (20 mm in diameter and 5 mm in thickness) of each sample.

[0108] The samples were placed in simulated body fluid (PBS buffer, pH 7.4).

[0109] Samples were taken at different time points and the drug concentration in the release solution was measured.

[0110] Conditions: 37°C constant temperature oscillator, 100 rpm.

[0111] Equipment: UV-Vis spectrophotometer.

[0112] 2. Skin healing experiment

[0113] Experimental group: group treated with double network skin repair hydrogel;

[0114] Control group 1: treated with comparative hydrogel;

[0115] Animal model: Healthy adult male rats were selected for group testing;

[0116] Wound preparation: A full-thickness skin excision wound with a diameter of 1 cm was prepared on the back of the rat;

[0117] Wound treatment: Apply a layer of double network skin repair hydrogel about 1 mm thick;

[0118] Evaluation indicators: wound contraction rate; wound photos were taken on days 1, 5, and 9.

[0119] Table 1 Drug release test table (mg / L)

[0120]

[0121]

[0122] The drug release of all examples from 1 hour to 72 hours was significantly higher than that of Comparative Example 1 and Comparative Example 2, indicating that the improved double network hydrogel structure effectively improved the sustained release efficiency of the drug. The release of Example 1, Example 9 and Example 10 in 1 hour reached or exceeded the release of the comparative example in 4 hours, which shows the advantage of rapid release in the initial stage.

[0123] As time goes by, the drug release of all examples continues to increase and maintains a high release rate, showing excellent sustained release performance. At 72 hours, the release of Example 1 is the highest, reaching 29.4%, while the release of Comparative Example 1 and Comparative Example 2 is only 19.8% and 19.1%. This shows that the hydrogel provided by the present invention can maintain a high drug utilization efficiency in long-term treatment.

[0124] Example 1 performed well at all time points, especially in the later period (48 hours and 72 hours), with drug release significantly higher than that of other examples and comparative examples. This may be related to its specific components and preparation conditions, such as the higher mass ratio of silver nanoparticles to azathioprine in the initial stage.

[0125] Example 9 and Example 10 show the effect of temperature and time on drug release behavior by changing the heating temperature and time. In particular, the release amount of Example 9 at all time points is higher than that of Example 10, which indicates that higher heating temperature and longer stirring time have a positive effect on the sustained release of the drug.

[0126] The results show that appropriately increasing the amount of network crosslinking agent (MBA) and adjusting the mass ratio of polymers constituting the network (such as PNIPAM and PEG) are helpful to optimize the drug release behavior. Adjusting the amount of MBA in Example 6 and Example 7 significantly affects the drug release, and has better release control compared with the comparative example.

[0127] The present invention achieves a combination of rapid initial release of the drug and slow release in the later stage by precisely controlling the cross-linking density and cross-linking conditions of the dual network structure, significantly improving the effect of drug release control. This feature is particularly suitable for the treatment of skin conditions that require long-term drug treatment, such as chronic dermatitis or skin repair, and provides an efficient and sustainable treatment plan.

[0128] Table 2 Wound healing rate statistics

[0129] Time Example 1 Comparative Example 1 Comparative Example 2 1 day (% healing rate standard deviation) 12.15±1.25 8.40±0.91 7.85±1.12 5 days (% healing rate ± standard deviation) 44.25±2.46 32.60±2.53 28.95±3.07 9 days (% healing rate ± standard deviation) 86.75±3.35 67.35±3.62 63.40±3.74

[0130] The double network structure and specific drug carrier (functionalized MOFs) used in Example 1 obviously provide better therapeutic effects, especially in terms of rapid initiation and continuous promotion of the healing process. This is related to its efficient drug release mechanism and excellent gel structure, which provide a favorable microenvironment for cell growth and tissue regeneration. Example 1 significantly improves the healing efficiency of skin wounds by using advanced material technology and sophisticated chemical engineering methods. Its double network hydrogel not only accelerates wound closure, but also optimizes the treatment process by controlling drug release, making it have potential application prospects in the field of skin repair. The comparative example is obviously not as sophisticated as Example 1 in terms of the design of the drug carrier and the optimization of the network structure, resulting in its low healing efficiency.

[0131] Figure 1 It shows that the treatment method in Example 1 is the most effective in promoting wound healing, showing the largest reduction in wound area within 9 days. The control treatments (Comparative Examples 1 and 2) are less effective, with slower healing speeds and still large wound areas after 9 days. The pictures show the superior performance of the treatment method in Example 1 in enhancing wound healing, which is better than the control treatment.

[0132] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for preparing a double network skin repair hydrogel, characterized in that: The following steps are involved: S1: dissolving 2-aminoterephthalic acid and copper nitrate in N,N-dimethylformamide and stirring until completely dissolved; then heating for reaction, cooling to room temperature, centrifuging to obtain MOFs solid, and then washing and drying to constant weight to obtain MOFs powder; S2: Re-dispersing the MOFs powder in deionized water to form a MOFs suspension, adding silver nanoparticles to the MOFs solution, stirring evenly, and obtaining a functionalized MOFs solution; S3 drug loading: dissolve azathioprine in deionized water, add it to the functionalized antibacterial MOFs solution, and treat it with ultrasound to obtain functionalized drug carrier MOFs; S4 first network: dissolving poly(N-isopropylacrylamide) and polyethylene glycol in deionized water, adding N,N'-methylenebisacrylamide, heating and stirring to form a preliminary cross-linked gel network; S5 Second Network: Disperse 50% of the functionalized drug carrier MOFs evenly in the first network gel, stir evenly, add N,N'-methylenebisacrylamide as a secondary crosslinking agent again, and then add the remaining functionalized drug carrier MOFs, heat and stir to form a completely crosslinked double network hydrogel, cool to room temperature, and stand at low temperature to form a gel; S6 Finally, pour the gel into the mold and leave it to solidify.

2. The method for preparing the double network skin repair hydrogel according to claim 1, characterized in that: In the step S1, 2-aminoterephthalic acid is 2-4 parts, copper nitrate is 1.5-2.5 parts, and N,N-dimethylformamide is 90-110 parts.

3. The method for preparing the double network skin repair hydrogel according to claim 1, characterized in that: In the step S1, the heating temperature is 150° C. and the reaction time is 10-14 hours.

4. The method for preparing the double network skin repair hydrogel according to claim 1, characterized in that: In the step S2, the MOFs powder is 2-4 parts, the deionized water is 90-110 parts, and the silver nanoparticles are 0.5-1.5 parts.

5. The method for preparing the double network skin repair hydrogel according to claim 1, characterized in that: In step S3, the amount of azathioprine is 0.4-0.6 parts, and the amount of deionized water is 10-20 parts.

6. The method for preparing the double network skin repair hydrogel according to claim 1, characterized in that: In step S4, poly(N-isopropylacrylamide) is 8-12 parts, polyethylene glycol is 4-6 parts, deionized water is 90-110 parts, N,N'-methylenebisacrylamide is 0.2-0.4 parts, the heating temperature is 60-70 degrees Celsius, and the time is 20-30 minutes.

7. The method for preparing the double network skin repair hydrogel according to claim 1, characterized in that: In the step S5, the amount of N,N'-methylenebisacrylamide is 0.4-0.6 parts.

8. The method for preparing the double network skin repair hydrogel according to claim 1, characterized in that: In step S5, the heating temperature is 70-80 degrees Celsius and the stirring time is 30-40 minutes.

9. The method for preparing the double network skin repair hydrogel according to claim 1, characterized in that: In step S6, the standing temperature is 4° C. and the standing time is 1-2 hours.

10. A double network skin repair hydrogel, characterized in that: Prepared by any one of claims 1-9.

Citation Information

Patent Citations

  • Hydrogel active dressing with antibacterial and anti-inflammatory functions

    CN112370567A

  • Composite hydrogel and preparation method and application thereof

    CN112646089A

  • Sustained-release carrier, chlorine dioxide gel composition containing sustained-release carrier and application thereof

    CN112661899A

  • Hydrogel phase change cold storage material, preparation method and application

    CN114685816A